PLUS

HEADLINES TREATMENT REGIMENS FROM THE ADVISORY BOARD PUBLISHERS ALLIANCE TOOLS MULTIMEDIA CME

Latest News

Promising HPV Vaccine Receives Development Funding from the National Cancer Institute

Promising HPV Vaccine Receives Development Funding from the National Cancer Institute

The National Cancer Institute (NCI) has funded $3.5 million for the development of a new human papillomavirus (HPV) vaccine.

Androgen Deprivation Therapy Raises Heart-Related Death Risk

Androgen Deprivation Therapy Raises Heart-Related Death Risk

But the overall risk of cardiac death from androgen deprivation for prostate cancer patients is small.

For Patients With a Positive Sentinel Node in Breast Cancer, Radiotherapy is Comparable to Dissection

For Patients With a Positive Sentinel Node in Breast Cancer, Radiotherapy is Comparable to Dissection

Radiotherapy of the axillary lymph node following a positive sentinel node effective approach in breast cancer.

FIT Screening May Be as Effective as Colonoscopy in Detecting Familial Colorectal Cancer

FIT Screening May Be as Effective as Colonoscopy in Detecting Familial Colorectal Cancer

Fecal immunochemical testing may be as effective as colonoscopies in being able to detect colorectal cancer risk.

Lenalidomide Plus Rituximab May Be Effective in Patients with Untreated Indolent Non-Hodgkin Lymphoma

Lenalidomide Plus Rituximab May Be Effective in Patients with Untreated Indolent Non-Hodgkin Lymphoma

Lenalidomide in combination with rituximab is safe and effective as initial therapy for non-Hodgkin lymphoma.

In Breast Cancer Survivors, Depression Lingers

In Breast Cancer Survivors, Depression Lingers

Breast cancer survivors found more likely to need hospital care, antidepressants than cancer-free women.

Burnout Found in Most Palliative Care Clinicians

Burnout Found in Most Palliative Care Clinicians

Greatest risk of burnout in palliative care for younger doctors and those working more than 50 hours per week.

Trastuzumab Plus Vinorelbine May Be an Effective Alternative for HER2-Positive Breast Cancer

Trastuzumab Plus Vinorelbine May Be an Effective Alternative for HER2-Positive Breast Cancer

Trastuzumab and vinorelbine an effective alternative to standard taxane-based chemotherapy for HER2-positive breast cancer.

For Breast Cancer, Rapamycin Plus Dasatinib May Be Effective

For Breast Cancer, Rapamycin Plus Dasatinib May Be Effective

Dual therapy with rapamycin (sirolimus) and dasatinib may be an effective treatment for breast cancer.

Link Found Between Number of Sexual Partners and Prostate Cancer Risk

Link Found Between Number of Sexual Partners and Prostate Cancer Risk

Link found between a man's number of female sexual partners and his risk of getting prostate cancer.

Limited Time for Discussion, Limited Access to Secondary Supports Among Barriers to Palliative Care

Limited Time for Discussion, Limited Access to Secondary Supports Among Barriers to Palliative Care

Palliative Care in Oncology Symposium: Limited time, support, and case management among barriers that hinder ability to provide palliative care.

Severe Tenesmoid Cancer Pain Managed with Bupivacaine Via Intrathecal and Rectal Administration

Severe Tenesmoid Cancer Pain Managed with Bupivacaine Via Intrathecal and Rectal Administration

Successful management of severe cancer pain can be a challenge for oncologists and their patients.

Mindfulness Improves Cancer-Related Quality of Life and Decreases Emotional Stress

Mindfulness Improves Cancer-Related Quality of Life and Decreases Emotional Stress

Palliative Care in Oncology Symposium: Dispositional mindfulness may promote flourishing when confronting cancer.

Improved Quality of Life in Patients with Advanced Prostate Cancer When Treated with Degarelix Compared with Leuprorelin

Improved Quality of Life in Patients with Advanced Prostate Cancer When Treated with Degarelix Compared with Leuprorelin

Researchers used degarelix trial questionnaire to address lack of evidence-based information related to quality of life issues in prostate cancer patients.

Keytruda Designated Breakthrough Status by FDA for Treatment of Non-Small Cell Lung Cancer (NSCLC)

Keytruda Designated Breakthrough Status by FDA for Treatment of Non-Small Cell Lung Cancer (NSCLC)

FDA has designated Keytruda (pembrolizumab) as breakthrough therapy for ALK-negative non-small cell lung cancer (NSCLC).

More News

Health Care Expenditure Slowed in US

Health sector prices explain much of difference between U.S. and other high-spending countries.

States Concerned About Higher-Than-Expected Medicaid Enrollment

Millions signing up for Medicaid to comply with federal health care law.

EHR Use More Than Doubles

Almost 80% of doctors in the United States have switched from paper to electronic health records.

Many Docs Order Unnecessary Medical Tests

Most physicians believe that doctors order too many medical tests, yet half admit to doing so themselves in response to a patient who insists, a new survey shows.

Reducing Six Risk Factors May Prevent 37 Million Deaths

Several modifiable risk factors can cut chronic disease deaths over the next 15 years.

Majority of Women Lack Accurate Knowledge of Their Own Breast Cancer Risk

Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.

Survey Identifies Modifiable Barriers to Mammography Screening Among Rural US Women

A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.

Perioperative MRI of Uncertain Benefit for Women with DCIS

The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.

Dr. Edith Perez's Recommended Abstracts at BCS 2013

ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.

Radiotherapy for DCIS Is Not Associated With Increased Cardiovascular Disease

Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs